Laporan Laba Rugi (TTM)
Laporan Laba Rugi DanCann Pharma A/S menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2021 03-31 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -0 | 0 | 1 | 2 | 4 | 4 | 7 | 7 | 7 | 8 | 7 | 7 | 7 | 8 | 8 | 7 | 7 | 4 |
| Change (%) | -165.91 | 273.02 | 122.28 | 58.92 | 19.90 | 52.03 | 7.67 | -8.54 | 23.73 | -9.99 | -2.31 | -4.47 | 17.42 | -0.07 | -8.05 | -6.21 | -38.56 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 4 | 8 | 9 | 10 | 12 | 13 | 13 | 13 | 11 | 10 | 11 | 10 | 10 | 9 | 8 | 7 | 7 | |
| Change (%) | 83.27 | 8.23 | 13.96 | 19.65 | 11.91 | -3.92 | -2.92 | -12.25 | -6.93 | 6.34 | -6.82 | 0.45 | -7.96 | -17.09 | -5.70 | -1.37 | ||
| % of Revenue | 1,595.68 | 783.99 | 381.74 | 273.74 | 273.16 | 201.08 | 179.44 | 190.46 | 135.08 | 139.67 | 152.03 | 148.30 | 126.87 | 116.86 | 105.37 | 105.94 | 170.08 | |
| Gross Operating Profit | -0 | -4 | -7 | -6 | -6 | -8 | -7 | -6 | -6 | -3 | -3 | -4 | -3 | -2 | -1 | -0 | -0 | -3 |
| Change (%) | 885.78 | 70.59 | -8.44 | -2.00 | 19.50 | -11.26 | -15.38 | 4.15 | -52.02 | 1.79 | 28.12 | -11.34 | -34.67 | -37.29 | -70.71 | 3.79 | 624.33 | |
| % of Revenue | 100.00 | -1,495.68 | -683.99 | -281.74 | -173.74 | -173.16 | -101.08 | -79.44 | -90.46 | -35.08 | -39.67 | -52.03 | -48.30 | -26.87 | -16.86 | -5.37 | -5.94 | -70.08 |
| SG&A | 2 | 4 | 5 | 7 | 8 | 8 | 8 | 9 | 9 | 9 | 10 | 9 | 8 | 7 | 6 | 5 | 5 | 5 |
| Change (%) | 55.55 | 28.04 | 44.74 | 9.00 | 4.03 | -1.47 | 7.01 | 8.82 | 1.81 | 7.01 | -6.40 | -12.27 | -16.29 | -18.11 | -16.00 | -1.93 | 0.90 | |
| % of Revenue | -585.87 | 1,382.73 | 474.64 | 309.07 | 211.98 | 183.93 | 119.20 | 118.47 | 140.96 | 115.99 | 137.90 | 132.13 | 121.34 | 86.50 | 70.89 | 64.76 | 67.72 | 111.21 |
| R&D | ||||||||||||||||||
| Change (%) | ||||||||||||||||||
| % of Revenue | ||||||||||||||||||
| OpEx | 3 | 8 | 14 | 17 | 19 | 22 | 24 | 24 | 24 | 23 | 23 | 67 | 66 | 64 | 62 | 15 | 14 | 14 |
| Change (%) | 237.99 | 59.83 | 24.09 | 13.78 | 14.18 | 7.64 | 0.41 | 0.28 | -4.40 | -0.46 | 198.60 | -2.44 | -2.56 | -3.30 | -76.51 | -3.72 | -0.44 | |
| % of Revenue | -594.62 | 3,049.28 | 1,306.56 | 729.41 | 522.25 | 497.31 | 352.12 | 328.38 | 360.05 | 278.19 | 307.68 | 940.42 | 960.44 | 797.02 | 771.34 | 197.03 | 202.27 | 327.75 |
| Operating Income | -3 | -8 | -13 | -15 | -15 | -17 | -17 | -16 | -17 | -14 | -15 | -60 | -59 | -56 | -54 | -7 | -7 | -10 |
| Change (%) | 179.84 | 52.60 | 15.95 | 6.61 | 12.82 | -3.53 | -2.47 | 4.14 | -15.22 | 4.90 | 295.34 | -2.20 | -4.88 | -3.76 | -86.71 | -1.15 | 36.83 | |
| % of Revenue | 694.62 | -2,949.28 | -1,206.56 | -629.41 | -422.25 | -397.31 | -252.12 | -228.38 | -260.05 | -178.19 | -207.68 | -840.42 | -860.44 | -697.02 | -671.34 | -97.03 | -102.27 | -227.75 |
| Interest Expense | -0 | -0 | -0 | -1 | -2 | -3 | -4 | -3 | -3 | -2 | -3 | -2 | -2 | -2 | -2 | -1 | -1 | -1 |
| Change (%) | 160.04 | -6.88 | 742.28 | 71.71 | 31.74 | 24.69 | -14.60 | -8.93 | -16.85 | 13.63 | -10.50 | -4.04 | 3.80 | -31.91 | -15.52 | -34.93 | -28.46 | |
| % of Revenue | 14.59 | -57.55 | -14.37 | -54.45 | -58.83 | -64.64 | -53.02 | -42.05 | -41.87 | -28.14 | -35.52 | -32.55 | -32.69 | -28.90 | -19.70 | -18.10 | -12.55 | -14.62 |
| Net Income | -2 | -6 | -9 | -12 | -13 | -15 | -15 | -16 | -16 | -16 | -16 | -62 | -62 | -57 | -58 | -8 | -8 | -11 |
| Change (%) | 141.09 | 55.44 | 32.75 | 11.93 | 13.93 | -0.05 | 7.26 | 2.19 | -1.22 | -3.45 | 297.70 | -0.27 | -7.87 | 1.21 | -85.59 | -5.24 | 42.56 | |
| % of Revenue | 559.94 | -2,048.20 | -853.52 | -509.76 | -359.05 | -341.17 | -224.29 | -223.45 | -249.66 | -199.31 | -213.81 | -870.40 | -908.71 | -713.05 | -722.25 | -113.21 | -114.39 | -265.42 |
Source: Capital IQ
